questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Hémoprotéines
Cytochromes
Cytochrome P-450 enzyme system
Steroid hydroxylases
Cholestanetriol 26-monooxygenase
Cholestanetriol 26-monooxygenase : Questions médicales fréquentes
Termes MeSH sélectionnés :
Genetic Predisposition to Disease
Diagnostic
5
Déficience enzymatique
Cholestérol
Tests génétiques
Cholestérol
Tests sanguins
Métabolisme
Symptômes
Troubles hormonaux
Maladies hépatiques
Cholestanol
Marqueurs biologiques
Cholestérol
Imagerie médicale
Anomalies hépatiques
Troubles métaboliques
Symptômes
5
Fatigue
Douleurs abdominales
Troubles hormonaux
Troubles neurologiques
Déséquilibres hormonaux
Symptômes
Éruptions cutanées
Troubles métaboliques
Symptômes
Évolution des symptômes
Déficience
Traitement
Prévention
5
Prévention
Alimentation équilibrée
Suivi médical
Dépistage
Cholestérol
Risque
Antécédents familiaux
Troubles lipidiques
Risque
Mode de vie
Tabac
Activité physique
Gestion du stress
Équilibre hormonal
Métabolisme
Traitements
5
Traitements
Modifications diététiques
Suppléments
Médicaments
Régulation du cholestérol
Traitements
Thérapies alternatives
Acupuncture
Efficacité
Nutrition
Acides gras essentiels
Santé métabolique
Mode de vie
Exercice
Recommandations
Complications
5
Complications
Troubles hormonaux
Maladies hépatiques
Maladies cardiovasculaires
Risque
Déficience
Gestion des complications
Traitements médicaux
Mode de vie
Réversibilité
Traitement
Complications
Signes d'alerte
Jaunisse
Fatigue extrême
Facteurs de risque
5
Facteurs de risque
Obésité
Mode de vie sédentaire
Alimentation
Graisses saturées
Risque
Sexe
Risque
Troubles lipidiques
Stress
Déséquilibres hormonaux
Métabolisme
Âge
Risque
Troubles lipidiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cholestanetriol 26-monooxygenase : Questions médicales les plus fréquentes",
"headline": "Cholestanetriol 26-monooxygenase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cholestanetriol 26-monooxygenase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cholestanetriol 26-monooxygenase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Steroid hydroxylases",
"url": "https://questionsmedicales.fr/mesh/D013250",
"about": {
"@type": "MedicalCondition",
"name": "Steroid hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D013250",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.915"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cholestanetriol 26-monooxygenase",
"alternateName": "Cholestanetriol 26-Monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D053493",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dirk Tischler",
"url": "https://questionsmedicales.fr/author/Dirk%20Tischler",
"affiliation": {
"@type": "Organization",
"name": "Microbial Biotechnology, Faculty of Biology and Biotechnology, Ruhr-Universität Bochum, Bochum, Germany. Electronic address: dirk.tischler@rub.de."
}
},
{
"@type": "Person",
"name": "Bastien Bissaro",
"url": "https://questionsmedicales.fr/author/Bastien%20Bissaro",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), N-1432 Ås, Norway."
}
},
{
"@type": "Person",
"name": "Vincent G H Eijsink",
"url": "https://questionsmedicales.fr/author/Vincent%20G%20H%20Eijsink",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Chemistry, Biotechnology and Food Science, NMBU-Norwegian University of Life Sciences, Ås, Norway. Electronic address: vincent.eijsink@nmbu.no."
}
},
{
"@type": "Person",
"name": "Roland Ludwig",
"url": "https://questionsmedicales.fr/author/Roland%20Ludwig",
"affiliation": {
"@type": "Organization",
"name": "Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 11, 1190 Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Zarah Forsberg",
"url": "https://questionsmedicales.fr/author/Zarah%20Forsberg",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), N-1432 Ås, Norway."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer's Disease.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37175659",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24097955"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36271292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22711-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hemophagocytic Lymphohistiocytosis in Adolescents and Young Adults: Genetic Predisposition and Secondary Disease.",
"datePublished": "2023-07-11",
"url": "https://questionsmedicales.fr/article/37951650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mcna.2023.05.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic predisposition to cancers in children and adolescents.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/36354292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001197"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic predisposition between coronavirus disease 2019 and rheumatic diseases: A 2-sample Mendelian randomization study.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36890668",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14624"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006420"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytochromes",
"item": "https://questionsmedicales.fr/mesh/D003580"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cytochrome P-450 enzyme system",
"item": "https://questionsmedicales.fr/mesh/D003577"
},
{
"@type": "ListItem",
"position": 7,
"name": "Steroid hydroxylases",
"item": "https://questionsmedicales.fr/mesh/D013250"
},
{
"@type": "ListItem",
"position": 8,
"name": "Cholestanetriol 26-monooxygenase",
"item": "https://questionsmedicales.fr/mesh/D053493"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cholestanetriol 26-monooxygenase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cholestanetriol 26-monooxygenase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cholestanetriol 26-monooxygenase",
"description": "Comment diagnostiquer une déficience en cholestanetriol 26-monooxygenase ?\nQuels tests sont utilisés pour évaluer l'activité de l'enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nY a-t-il des marqueurs spécifiques pour cette enzyme ?\nComment l'imagerie peut-elle aider dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D053493?mesh_terms=Genetic+Predisposition+to+Disease#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cholestanetriol 26-monooxygenase",
"description": "Quels sont les symptômes d'une déficience en cholestanetriol 26-monooxygenase ?\nPeut-on avoir des symptômes neurologiques ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes cutanés associés ?\nComment les symptômes évoluent-ils dans le temps ?",
"url": "https://questionsmedicales.fr/mesh/D053493?mesh_terms=Genetic+Predisposition+to+Disease#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cholestanetriol 26-monooxygenase",
"description": "Comment prévenir les troubles liés à cette enzyme ?\nY a-t-il des tests de dépistage recommandés ?\nLes antécédents familiaux influencent-ils la prévention ?\nQuels conseils de mode de vie peuvent aider ?\nLa gestion du stress est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D053493?mesh_terms=Genetic+Predisposition+to+Disease#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cholestanetriol 26-monooxygenase",
"description": "Quels traitements sont disponibles pour cette déficience ?\nLes médicaments peuvent-ils aider ?\nY a-t-il des thérapies alternatives recommandées ?\nComment la nutrition influence-t-elle le traitement ?\nLes changements de mode de vie sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D053493?mesh_terms=Genetic+Predisposition+to+Disease#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cholestanetriol 26-monooxygenase",
"description": "Quelles complications peuvent survenir avec cette déficience ?\nY a-t-il un risque accru de maladies cardiovasculaires ?\nComment les complications sont-elles gérées ?\nLes complications peuvent-elles être réversibles ?\nQuels sont les signes d'alerte des complications ?",
"url": "https://questionsmedicales.fr/mesh/D053493?mesh_terms=Genetic+Predisposition+to+Disease#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cholestanetriol 26-monooxygenase",
"description": "Quels sont les principaux facteurs de risque ?\nL'alimentation influence-t-elle le risque ?\nLe sexe joue-t-il un rôle dans le risque ?\nLe stress est-il un facteur de risque ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D053493?mesh_terms=Genetic+Predisposition+to+Disease#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en cholestanetriol 26-monooxygenase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses biochimiques peuvent confirmer la déficience."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité de l'enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux de cholestérol et de ses métabolites sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, des troubles hormonaux ou des problèmes hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour cette enzyme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de cholestérol et de cholestanol peuvent servir de marqueurs."
}
},
{
"@type": "Question",
"name": "Comment l'imagerie peut-elle aider dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut détecter des anomalies hépatiques associées à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en cholestanetriol 26-monooxygenase ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs abdominales et troubles hormonaux."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison de déséquilibres hormonaux."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se manifester différemment selon l'âge et le sexe."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent apparaître en raison de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils dans le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec le temps si la déficience n'est pas traitée."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés à cette enzyme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un suivi médical régulier peuvent aider à prévenir les troubles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage du cholestérol sont recommandés pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles lipidiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels conseils de mode de vie peuvent aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, limiter l'alcool et pratiquer une activité physique régulière sont conseillés."
}
},
{
"@type": "Question",
"name": "La gestion du stress est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut contribuer à un meilleur équilibre hormonal et métabolique."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour cette déficience ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des modifications diététiques et des suppléments de cholestérol."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aider à réguler les niveaux de cholestérol."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives recommandées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies alternatives comme l'acupuncture peuvent être envisagées, mais peu de preuves existent."
}
},
{
"@type": "Question",
"name": "Comment la nutrition influence-t-elle le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en acides gras essentiels peut améliorer la santé métabolique."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements de mode de vie comme l'exercice régulier sont souvent recommandés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec cette déficience ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications hépatiques et des troubles hormonaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de maladies cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience peut augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des traitements médicaux et des modifications du mode de vie."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la jaunisse, la fatigue extrême ou des douleurs abdominales doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'obésité et un mode de vie sédentaire sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter le risque de troubles."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines études montrent que le sexe peut influencer le risque de troubles lipidiques."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des déséquilibres hormonaux et métaboliques."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles lipidiques augmente avec l'âge."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Microbial Biotechnology, Faculty of Biology and Biotechnology, Ruhr-Universität Bochum, Bochum, Germany. Electronic address: dirk.tischler@rub.de.
Publications dans "Cholestanetriol 26-monooxygenase" :
4 publications dans cette catégorie
Affiliations :
Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), N-1432 Ås, Norway.
Publications dans "Cholestanetriol 26-monooxygenase" :
4 publications dans cette catégorie
Affiliations :
Faculty of Chemistry, Biotechnology and Food Science, NMBU-Norwegian University of Life Sciences, Ås, Norway. Electronic address: vincent.eijsink@nmbu.no.
Publications dans "Cholestanetriol 26-monooxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 11, 1190 Vienna, Austria.
Publications dans "Cholestanetriol 26-monooxygenase" :
3 publications dans cette catégorie
Affiliations :
Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), N-1432 Ås, Norway.
Publications dans "Cholestanetriol 26-monooxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Blacksburg, VA, 24061, USA; Center for Drug Discovery, Virginia Tech, Blacksburg, VA, 24061, USA. Electronic address: psobrado@vt.edu.
Publications dans "Cholestanetriol 26-monooxygenase" :
3 publications dans cette catégorie
Affiliations :
Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), PO Box 5003, 1432 Ås, Norway.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
Microbial Biotechnology, Faculty of Biology and Biotechnology, Ruhr-Universität Bochum, Bochum, Germany.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
Environmental Microbiology, Faculty of Chemistry and Physics, TU Bergakademie Freiberg, Freiberg, Germany.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
College of Agriculture, South China Agricultural University, Guangzhou 510642, China.
Sugarcane Research Laboratory, South China Agricultural University, Guangzhou 510642, China.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
College of Agriculture, South China Agricultural University, Guangzhou 510642, China.
Sugarcane Research Laboratory, South China Agricultural University, Guangzhou 510642, China.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
College of Agriculture, South China Agricultural University, Guangzhou 510642, China.
Sugarcane Research Laboratory, South China Agricultural University, Guangzhou 510642, China.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
College of Agriculture, South China Agricultural University, Guangzhou 510642, China.
Sugarcane Research Laboratory, South China Agricultural University, Guangzhou 510642, China.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
College of Agriculture, South China Agricultural University, Guangzhou 510642, China.
Sugarcane Research Laboratory, South China Agricultural University, Guangzhou 510642, China.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
College of Agriculture, South China Agricultural University, Guangzhou 510642, China.
Sugarcane Research Laboratory, South China Agricultural University, Guangzhou 510642, China.
Scientific Observing and Experimental Station of Crop Cultivation in South China, Ministry of Agriculture and Rural Areas, Guangzhou 510642, China.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA; email: baner025@umn.edu , jone2616@umn.edu , lipsc001@umn.edu.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA; email: baner025@umn.edu , jone2616@umn.edu , lipsc001@umn.edu.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA; email: baner025@umn.edu , jone2616@umn.edu , lipsc001@umn.edu.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.
Publications dans "Cholestanetriol 26-monooxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland. michel.gilliet@chuv.ch.
Publications dans "Cholestanetriol 26-monooxygenase" :
Alzheimer's disease (AD) is a prevalent type of dementia in elderly populations with a significant genetic component. The accumulating evidence suggests that AD involves a reconfiguration of the epige...
Autoimmune diseases and coronavirus disease 2019 (COVID-19) share many similarities. Concerns have arisen that autoimmune diseases may increase the susceptibility and severity of COVID-19. We used Men...
Hemophagocytic lymphohistiocytosis (HLH) is a disorder of impaired immune regulation resulting in hyperinflammation that is ultimately fatal if not treated. HLH is categorized into familial disease, c...
Childhood cancer is rare, but it remains the leading cause of disease-related mortality among children 1-14 years of age. As exposure to environmental factors is lower in children, inherited genetic f...
Current literature suggests that 10-18% of paediatric cancer patients have an underlying genetic susceptibility to their disease. With better knowledge and technology, more genes and syndromes are bei...
This review summarizes the current knowledge about different cancer predisposition syndromes, focusing on the diagnosis, genetic counselling, surveillance and future directions....
The causalities between the coronavirus disease 2019 (COVID-19) and the risk of rheumatic diseases remain unclear. The purpose of this study was to investigate the causal effect of COVID-19 on rheumat...
Single nucleotide polymorphisms (SNPs), acquired from published genome-wide association studies, were used to perform 2-sample Mendelian randomization (MR) on cases diagnosed with COVID-19 (n = 13 464...
The results revealed a causality between COVID-19 and rheumatic diseases with an odds ratio (OR) of 1.010 (95% confidence interval [CI], 1.006-1.013; P = .014). In addition, we observed that COVID-19 ...
This is the first study to use MR to explore the impact of COVID-19 on rheumatic diseases. From a genetic perspective, we found that COVID-19 could increase the risk of rheumatic diseases, such as PBC...
Diets rich in plant-based foods are associated with lower risks of non-alcoholic fatty liver disease (NAFLD), while the prospective evidence is limited. We aimed to examine longitudinal associations o...
This longitudinal cohort study included 159,222 participants (58.0 ± 8.0 years old, 55.7% female) free of NAFLD in the UK Biobank. We calculated the overall plant-based diet index (PDI), the healthful...
During a median follow-up of 9.5 years, 1541 new-onset NAFLD cases were documented. Compared to the lowest quintile, multivariable-adjusted hazard ratios (HRs) of NAFLD in the highest quintile were 0....
Higher intake of plant-based diets especially healthful plant-based diets was associated with lower NAFLD risk and liver fat content regardless of genetic susceptibility, whereas an unhealthful plant-...
Accumulating evidence has indicated that persistent human cytomegalovirus (HCMV) infection is associated with several cardiovascular diseases including atherosclerosis and coronary artery disease. How...
Single-nucleotide polymorphisms associated with anti-cytomegalovirus immunoglobulin (Ig) G levels were used as instrumental variables to estimate the causal effect of anti-cytomegalovirus IgG levels o...
In the IVW analysis, genetically predicted anti-cytomegalovirus IgG levels were suggestively associated with coronary artery disease with an odds ratio (OR) of 1.076 [95% CI, 1.009-1.147; p = 0.025], ...
Our findings first provide direct evidence that genetic predisposition of anti-cytomegalovirus IgG levels increases the risk of coronary artery disease, peripheral artery disease, and deep vein thromb...
The implementation of next-generation sequencing technologies has provided a sharp picture of the genetic variability in the components and regulators of the alternative pathway (AP) of the complement...
Current evidence on the relations of residential greenness with glucose homeostasis and type 2 diabetes (T2D) remained largely uncertain. Most importantly, no prior studies have investigated whether g...
We leveraged data from the UK Biobank prospective cohort study, with participants enrolled between 2006 and 2010. Residential greenness was assessed by using the Normalized Difference Vegetation Index...
Among 315,146 individuals (mean [SD] age, 56.59 [8.09] years), each one-unit increase in residential greenness was associated with reduction in HbA...
We add novel evidence that residential greenness has protective effects on glucose metabolism and T2D, and those beneficial effects can be amplified by low genetic risk. Our findings may facilitate th...
Thyroid hormones have actions on cartilage, whereas the association between thyroid hormone related diseases and osteoarthritis (OA) are unclear. This study aims to investigate the association between...
Summary-level genetic data of thyrotoxicosis were obtained from FinnGen cohorts (nCase = 10,569, nControl = 762,037). Summary-level data of OA were obtained from a large-scale genome-wide association ...
Genetic predisposition of thyrotoxicosis was associated with the onset of knee OA (autoimmune hyperthyroidism: odds ratio [OR]: 1.05, 95% confidence interval [CI]: 1.03-1.07, FDR < 0.001; thyrotoxicos...
This study provides MR evidence supporting causal association of thyrotoxicosis with knee OA in European population, whereas OA may have no causal effects on thyrotoxicosis....